Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017
November 08 2017 - 8:30AM
Business Wire
Dextera Surgical Inc. (Nasdaq: DXTR), a company commercializing
and developing the MicroCutter 5/80™ Stapler, today announced that
it plans to release its fiscal 2018 first quarter financial results
after the markets close on November 9, 2017, and will file its 10-Q
with the SEC within the required timeframe.
Dextera will not hold the previously announced conference call
on November 9 for investors in connection with the company’s
quarterly results.
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures. In the
U.S., surgical staplers are routinely used in more than one million
minimally invasive laparoscopic, video-assisted or robotic-assisted
surgical procedures annually.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold
by Dextera Surgical under the Cardica brand name, have
demonstrated long-term reliable clinical performance for more than
a decade.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108005400/en/
Dextera Surgical Inc.Bob Newell, 650-331-7133Vice President,
Finance and Chief Financial
Officerinvestors@dexterasurgical.com